vimarsana.com

Page 27 - விரிவாக்கப்பட்டது ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Displaced Children at Myaing Gyi Ngu IDP Camp Vaccinated

Displaced Children at Myaing Gyi Ngu IDP Camp Vaccinated Over 200 children at the Myaing Gyi Ngu internally displaced persons camp have received their first ever inoculations this week, amid a joint vaccination drive by the Karen Department of Health and Welfare and the state health department. Between July 4-6 children under five were given a slew of vaccines protecting against tuberculosis, tetanus, chickenpox, diphtheria, pertussis, hepatitis B, pneumococcal disease, measles and polio. “The children here [at the Myaing Gyi Ngu IDP shelter] are from areas where we couldn’t previously administer vaccines so they have never seen vaccines before,” said Dr Naing Naing Tun, deputy director of Karen State’s Expanded Program on Immunization. “Some of them ran away as they were afraid. They don’t understand the value of vaccines.”

What we know about Vietnam s homegrown COVID-19 vaccine, so far | Tuoi Tre News

Wednesday, December 16, 2020, 14:31 GMT+7 A researcher at Nanogen Pharmaceutical Biotechnology implementing tests on Nanocovax, Vietnam s first homegrown COVID-19 vaccine to be approved for human trial. Photo: Duyen Phan / Tuoi Tre Nanocovax – one of Vietnam’s domestically developed vaccines for COVID-19 – has officially received volunteers for its human clinical trial phase. Meanwhile, three other candidates are each running their own race to come up with an approved COVID-19 vaccine for mass inoculation. Developed by Vietnamese manufacturer Nanogen Pharmaceutical Biotechnology, Nanocovax will be brought to human trials under the supervision of the Vietnam Military Medical University. The vaccine roadmap Just one year ago on December 3, the first case of novel coronavirus infection was detected in China. Named COVID-19, the disease stemming from the SARS-CoV-2 pathogen managed to spread across the world, causing the most contagious and precarious epidemic in the last 100

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.